NIMHANS Applies for Permanent Registration under CMHA

According to the notice, interested parties have a window of 30 days from the date of publication to file objections. The objection form, inclusive of all necessary details, is made available for this purpose. Any objections should be submitted via email to within the stipulated timeframe.

New Drug Manufacturing Rules Introduced to Strengthen Quality Standards

The Amendment Rules introduce a new set of guidelines titled “GOOD MANUFACTURING PRACTICES AND REQUIREMENTS OF PREMISES, PLANT AND EQUIPMENT FOR PHARMACEUTICAL PRODUCTS” in Schedule M. The guidelines outline several key principles to be adhered to by pharmaceutical manufacturers, focusing on pharmaceutical quality systems, quality risk management, sanitation and hygiene, qualification and validation, complaints and adverse reactions, product recalls, and change control.

Union Health Minister Inaugurates CDSCO Sub Zonal office & CDTL in Indore

The Central Drug Testing Laboratory, equipped with high-quality laboratory services, will play a crucial role in testing drugs, ensuring the availability of essential and high-quality medicines to improve the health of citizens. The facility is equipped with advanced instruments, including 12 HPLCs, 1 GLC, and 1 UV Spectrophotometer.

Union Health Minister Inaugurates India’s First Healthy & Hygienic Food Street in MP

The Union Health Minister officially launched the website for the Healthy & Hygienic Food Street initiative and unveiled a brochure outlining the Standard Operating Procedure for these food streets. In addition to this, he also inaugurated 17 civil works, including two Public Health Unit blocks, 54 Chief Minister Sanjeevni Health Clinics, three Integrated Public Health Labs, an Emergency Covid response package, three Community Health Centres, and eight Primary Health Care Centres.

MedTech Mitra Launched To Empower Innovators in Healthcare

Acknowledging the import dependency of India’s MedTech sector, which stands at 80%, the Minister underscored the progress made through production-linked incentive schemes, investments in medical drug parks, and the implementation of the MedTech research policy and incentive scheme. The collaborative initiative of ‘MedTech Mitra’ is expected to drive indigenous development, making quality MedTech devices more affordable and reducing import dependence.

India Witnesses Reduction in Drug-Resistant TB Cases

India has scaled up the availability of molecular diagnostic facilities. This effort has resulted in an increased proportion of TB patients being screened for the presence of drug resistance. Under the National TB Elimination Programme (NTEP), there has also been a consistent and regular supply of Anti-TB drugs to all states and union territories (UTs) throughout the year.